Literature DB >> 8034895

Nitric oxide and nitrovasodilators: similarities, differences and potential interactions.

T J Anderson1, I T Meredith, P Ganz, A P Selwyn, A C Yeung.   

Abstract

Many similarities exist between the exogenous nitrates and endothelium-derived relaxing factor, which is nitric oxide or a thiol derivative. Both act by way of guanylate cyclase, which increases intracellular concentrations of cyclic guanosine monophosphate, resulting in smooth muscle cell relaxation and antiplatelet effects. Thiols may be important in the biotransformation of exogenous nitrates and other intracellular processes involving nitric oxide. As such, important interactions might be expected between nitrates and endothelium-dependent processes that involve nitric oxide. This review explores the mechanisms of action, biologic effects and potential interactions between nitrates and endothelium-derived relaxing factor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8034895     DOI: 10.1016/0735-1097(94)90316-6

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  14 in total

1.  Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function.

Authors:  M Iemura; M Ishii; T Sugimura; T Akagi; H Kato
Journal:  Heart       Date:  2000-03       Impact factor: 5.994

2.  Endothelin mediates renal vascular memory of a transient rise in perfusion pressure due to NOS inhibition.

Authors:  X Z Zhang; C Baylis
Journal:  Am J Physiol       Date:  1999-04

3.  Ocular pulse amplitude is reduced in patients with advanced retinitis pigmentosa.

Authors:  K G Schmidt; L E Pillunat; K Kohler; J Flammer
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

4.  Assessing progression or regression of CAD: the role of perfusion imaging.

Authors:  K Lance Gould
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

5.  A new class of organic nitrates: investigations on bioactivation, tolerance and cross-tolerance phenomena.

Authors:  S Schuhmacher; E Schulz; M Oelze; A König; C Roegler; K Lange; L Sydow; T Kawamoto; P Wenzel; T Münzel; J Lehmann; A Daiber
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

6.  Suppressed anti-aggregating and cGMP-elevating effects of sodium nitroprusside in platelets from patients with stable angina pectoris.

Authors:  Y Y Chirkov; L P Chirkova; J D Horowitz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

7.  Clinical pharmacokinetics of molsidomine.

Authors:  B Rosenkranz; B R Winkelmann; M J Parnham
Journal:  Clin Pharmacokinet       Date:  1996-05       Impact factor: 6.447

Review 8.  Redox regulation of guanylate cyclase and protein kinase G in vascular responses to hypoxia.

Authors:  Boon Hwa Neo; Sharath Kandhi; Mansoor Ahmad; Michael S Wolin
Journal:  Respir Physiol Neurobiol       Date:  2010-09-08       Impact factor: 1.931

Review 9.  Nitric oxide for the evaluation and treatment of pulmonary hypertension in congenital heart disease.

Authors:  J P Kovalchin; A R Mott; K L Rosen; T F Feltes
Journal:  Tex Heart Inst J       Date:  1997

10.  Quantification of glyceryl trinitrate effect through analysis of the synthesised ascending aortic pressure waveform.

Authors:  X J Jiang; M F O'Rourke; W Q L Jin; L S Liu; C W Li; P C Tai; X C Zhang; S Z Liu
Journal:  Heart       Date:  2002-08       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.